SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-02
👔
Camp4 Therapeutics Corp
@CAMP_InsiderForm 4 Filing: Gold Kelly Buys $40K of $CAMP
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Camp4 Therapeutics Corp
Ticker: $CAMP
Transaction Value
$40K
Price/Share: $3.96
transaction date
2026-08-31
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Gold Kelly, holds the title of Chief Financial Officer at Camp4 Therapeutics Corp.
On 2026-08-31, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $3.96 per share, resulting in a total market-relevant value of $40K.
Executive Summary Summary
Gold Kelly (Chief Financial Officer) bought $40K of $CAMP
Post-Transaction Position: 10,000 shares
SEC Accession No: 0001628280-26-060234 (CIK: 2033333)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.